Canada
US
Results of Lucira’s COVID-19 & Flu Test Study
If the SARS-CoV-2 or Influenza A or B viruses is present in a sample, Lucira’s innovative platform is designed to find it and amplify the virus’s genetic material while the test is running, just like PCR lab tests. In the retrospective studies described to the left, Lucira’s amplification method provides a level of accuracy comparable to market-leading PCR lab tests.
Lucira’s COVID-19 & Flu Test achieved 99% accuracy for COVID-19 and flu in head-to-head comparison with the Roche cobas and the Quidel Lyra, respectively.
